Content
The Steno Thursdays events aim to disseminate exciting diabetes research from clinical- and biomedicine to epidemiology. Most presentations are given by researchers affiliated to or collaborating with SDCA. We host Steno Thursdays Global once a month, featuring international diabetes experts.
There will be room for questions and discussions following every talk.
How often
Thursdays, 14:15-15:00 in Verdensrummet, Steno Diabetes Center Aarhus
PROGRAMME: March
Thursday 7
Speaker: Jakob Wang PhD, PostDoc Steno Diabetes Center Aarhus and Dept. of Biomedicine, Aarhus University
"The Skeletal Muscle Microenvironment - Lessons learned from across human studies "
Summary: In recent years, our group have been enganged in several research projects investigating alterations the cellular landscape of the skeletal muscle microenvironment across various disease states and interventional pertubations. In this presentation, I will outline the recent advancements in understanding of the cellular dynamics that governs skeletal muscle homeostasis. In this context I will draw perspectives to selected results from our past and ongoing studies aiming to untangle the skeletal
muscle microenvironment at health, disease and in response to exercise.
March 14
Steno Global
Speaker: Michael Wosczyna Assistant Professor, Kimmel Center for Stem Cell Biology, New York University, Grossman School of Medicine, USA
"Mesenchymal Stem Cells as Essential Regulators of Tissue Health"
Summary: The Wosczyna Lab investigates the cellular and molecular mechanisms of tissue health. We are particularly interested in mesenchymal stem cells and how they regulate tissue regeneration, maintenance, pathology, and aging. We model these fundamental processes in skeletal muscle and adipose tissue to reveal targetable mechanisms for restoring organs when their functions are impaired.
Participation through Zoom: Link for online participation via Zoom
Meeting ID: 622 0478 9249
March 21 - 14:00
PhD defense: " GF1 and its regulatory proteins, including PAPP-A and STC2, in atherosclerosis and cardiovascular disease".
Mette Faurholdt Gude, PhD student Steno Diabetes Center Aarhus
Summary: IGF-I and its regulatory proteins appear to be significant in the development of atherosclerosis and, consequently, in influencing the risk of cardiovascular disease. A new PhD project from Aarhus University, Health, combines three studies examining the correlation with atherosclerosis, cardiovascular disease, and mortality. The studies investigate Stanniocalcin-2 (STC2), Pregnancy-associated plasma protein-A (PAPP-A), Insulin-like growth factor binding protein-4 (IGFBP4), and Insulin-like growth factor I (IGF-I) in both plasma and atherosclerotic tissue (plaque) extracted during surgery.
March 28
Easter break
How to join
Talks are announced through e-mails and Slack. Everyone can join.
Steno Thursdays Global talks are also announced online and on Twitter @StenoAarhusRes. Meetings are held at Steno Diabetes Center Aarhus (Forum, AUH) or in Dept. of endocrinology AUH, Conference room (J102-111).
Contact persons